162 related articles for article (PubMed ID: 36831354)
21. MRI-based tumor inter-fraction motion statistics for rectal cancer boost radiotherapy.
Kleijnen JJE; van Asselen B; Van den Begin R; Intven M; Burbach JPM; Reerink O; Philippens MEP; de Ridder M; Lagendijk JJW; Raaymakers BW
Acta Oncol; 2019 Feb; 58(2):232-236. PubMed ID: 30444161
[TBL] [Abstract][Full Text] [Related]
22. Prostate intrafraction motion during the preparation and delivery of MR-guided radiotherapy sessions on a 1.5T MR-Linac.
de Muinck Keizer DM; Kerkmeijer LGW; Willigenburg T; van Lier ALHMW; Hartogh MDD; van der Voort van Zyp JRN; de Groot-van Breugel EN; Raaymakers BW; Lagendijk JJW; de Boer JCJ
Radiother Oncol; 2020 Oct; 151():88-94. PubMed ID: 32622779
[TBL] [Abstract][Full Text] [Related]
23. Magnetic resonance image-guided adaptive radiotherapy enables safe CTV-to-PTV margin reduction in prostate cancer: a cine MRI motion study.
Westley RL; Alexander SE; Goodwin E; Dunlop A; Nill S; Oelfke U; McNair HA; Tree AC
Front Oncol; 2024; 14():1379596. PubMed ID: 38894866
[TBL] [Abstract][Full Text] [Related]
24. Target coverage and dose criteria based evaluation of the first clinical 1.5T MR-linac SBRT treatments of lymph node oligometastases compared with conventional CBCT-linac treatment.
Winkel D; Bol GH; Werensteijn-Honingh AM; Intven MPW; Eppinga WSC; Hes J; Snoeren LMW; Sikkes GG; Gadellaa-van Hooijdonk CGM; Raaymakers BW; Jürgenliemk-Schulz IM; Kroon PS
Radiother Oncol; 2020 May; 146():118-125. PubMed ID: 32146257
[TBL] [Abstract][Full Text] [Related]
25. A comparative study of prostate PTV margins for patients using hydrogel spacer or rectal balloon in proton therapy.
Su Z; Henderson R; Nichols R; Bryant C; Hoppe B; Mendenhall W; Mendenhall N
Phys Med; 2021 Jan; 81():47-51. PubMed ID: 33378728
[TBL] [Abstract][Full Text] [Related]
26. Coping with interfraction time trends in tumor setup.
Giżyńska MK; Kukołowicz PF; Heijmen BJM
Med Phys; 2020 Feb; 47(2):331-341. PubMed ID: 31721232
[TBL] [Abstract][Full Text] [Related]
27. The impact of training and professional collaboration on the interobserver variation of lung cancer delineations: a multi-institutional study.
Mercieca S; Belderbos JSA; van Baardwijk A; Delorme S; van Herk M
Acta Oncol; 2019 Feb; 58(2):200-208. PubMed ID: 30375905
[TBL] [Abstract][Full Text] [Related]
28. Feasibility study of adaptive radiotherapy for esophageal cancer using artificial intelligence autosegmentation based on MR-Linac.
Wang H; Liu X; Song Y; Yin P; Zou J; Shi X; Yin Y; Li Z
Front Oncol; 2023; 13():1172135. PubMed ID: 37361583
[TBL] [Abstract][Full Text] [Related]
29. Reduction of prostate intrafraction motion using gas-release rectal balloons.
Su Z; Zhao T; Li Z; Hoppe B; Henderson R; Mendenhall W; Nichols RC; Marcus R; Mendenhall N
Med Phys; 2012 Oct; 39(10):5869-73. PubMed ID: 23039625
[TBL] [Abstract][Full Text] [Related]
30. Quantification of Esophageal Tumor Motion and Investigation of Different Image-Guided Correction Strategies.
Voncken FEM; Nakhaee S; Stam B; Wiersema L; Vollenbrock SE; van Dieren JM; van Leerdam ME; Sonke JJ; Aleman BMP; Remeijer P
Pract Radiat Oncol; 2020; 10(2):84-92. PubMed ID: 31786235
[TBL] [Abstract][Full Text] [Related]
31. Inter- and intrafraction uncertainty in prostate bed image-guided radiotherapy.
Huang K; Palma DA; Scott D; McGregor D; Gaede S; Yartsev S; Bauman G; Louie AV; Rodrigues G
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):402-7. PubMed ID: 22381905
[TBL] [Abstract][Full Text] [Related]
32. First Experience and Prospective Evaluation on Feasibility and Acute Toxicity of Online Adaptive Radiotherapy of the Prostate Bed as Salvage Treatment in Patients with Biochemically Recurrent Prostate Cancer on a 1.5T MR-Linac.
Wegener D; Thome A; Paulsen F; Gani C; Boldt J; Butzer S; Thorwarth D; Moennich D; Nachbar M; Müller AC; Zips D; Boeke S
J Clin Med; 2022 Aug; 11(16):. PubMed ID: 36012885
[TBL] [Abstract][Full Text] [Related]
33. A novel approach for radiotherapy dose escalation in rectal cancer using online MR-guidance and rectal ultrasound gel filling - Rationale and first in human.
Gani C; Lo Russo M; Boeke S; Wegener D; Gatidis S; Butzer S; Boldt J; Mönnich D; Thorwarth D; Nikolaou K; Zips D; Nachbar M
Radiother Oncol; 2021 Nov; 164():37-42. PubMed ID: 34534612
[TBL] [Abstract][Full Text] [Related]
34. Analysis of online plan adaptation for 1.5T magnetic resonance-guided stereotactic body radiotherapy (MRgSBRT) of prostate cancer.
Poon DMC; Yang B; Geng H; Wong OL; Chiu ST; Cheung KY; Yu SK; Chiu G; Yuan J
J Cancer Res Clin Oncol; 2023 Feb; 149(2):841-850. PubMed ID: 35199189
[TBL] [Abstract][Full Text] [Related]
35. Online adaptive radiotherapy for head and neck cancers on the MR linear Accelerator: Introducing a novel modified Adapt-to-Shape approach.
Gupta A; Dunlop A; Mitchell A; McQuaid D; Nill S; Barnes H; Newbold K; Nutting C; Bhide S; Oelfke U; Harrington KJ; Wong KH
Clin Transl Radiat Oncol; 2022 Jan; 32():48-51. PubMed ID: 34849412
[TBL] [Abstract][Full Text] [Related]
36. Intra-fractional bladder motion and margins in adaptive radiotherapy for urinary bladder cancer.
Grønborg C; Vestergaard A; Høyer M; Söhn M; Pedersen EM; Petersen JB; Agerbæk M; Muren LP
Acta Oncol; 2015; 54(9):1461-6. PubMed ID: 26313410
[TBL] [Abstract][Full Text] [Related]
37. Intrafraction motion during partial breast irradiation depends on treatment time.
Hoekstra N; Habraken S; Swaak-Kragten A; Hoogeman M; Pignol JP
Radiother Oncol; 2021 Jun; 159():176-182. PubMed ID: 33798609
[TBL] [Abstract][Full Text] [Related]
38. Feasibility of ablative stereotactic body radiation therapy of pancreas cancer patients on a 1.5 Tesla magnetic resonance-linac system using abdominal compression.
Tyagi N; Liang J; Burleson S; Subashi E; Godoy Scripes P; Tringale KR; Romesser PB; Reyngold M; Crane CH
Phys Imaging Radiat Oncol; 2021 Jul; 19():53-59. PubMed ID: 34307919
[TBL] [Abstract][Full Text] [Related]
39. Assessment of planning target volume margins for intensity-modulated radiotherapy of the prostate gland: role of daily inter- and intrafraction motion.
Tanyi JA; He T; Summers PA; Mburu RG; Kato CM; Rhodes SM; Hung AY; Fuss M
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1579-85. PubMed ID: 20472357
[TBL] [Abstract][Full Text] [Related]
40. Impact of magnetic resonance-guided versus conventional radiotherapy workflows on organ at risk doses in stereotactic body radiotherapy for lymph node oligometastases.
Werensteijn-Honingh AM; Kroon PS; Winkel D; van Gaal JC; Hes J; Snoeren LMW; Timmer JK; Mout CCP; Bol GH; Kotte AN; Eppinga WSC; Intven M; Raaymakers BW; Jürgenliemk-Schulz IM
Phys Imaging Radiat Oncol; 2022 Jul; 23():66-73. PubMed ID: 35814260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
